Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Ulcerative Colitis Clinical Trials in Chicago | 40 Studies

Clinical Trials Ulcerative ColitisChicago

Ulcerative Colitis Clinical Trials in Chicago

Find 40 clinical trials for ulcerative colitis near Chicago, Illinois. Connect with research centers in your area.

All Ulcerative Colitis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 40 trials

CompletedStudy to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative ColitisTo evaluate safety and efficacy of two adalimumab dosing regimens for induction and maintenance (standard and higher dosing) in achieving clinical remission in subjects with…NCT02065622·Dothan, Alabama and 172 others

Ulcerative Colitis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedEfficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative ColitisPrimary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658NCT01659138·Sun City, Arizona and 40 others

TerminatedEfficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisThe purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based on composite score of participant-reported symptoms and centrally read endoscopy, in…NCT03259334·Little Rock, Arkansas and 206 others

Not yet recruitingVR Therapies for IBDThrough a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT)…NCT07590518·Los Angeles, California and 1 other

Active not recruitingStudy to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).NCT05782907·Phoenix, Arizona and 88 others

CompletedWireless Capsule Endoscopy in Ulcerative ColitisBased on the inaccuracies of the current classification scheme for inflammatory bowel disease (IBD), the failure of surgical pouches and the findings of retrospective…NCT00145808·Chicago, Illinois

Not yet recruitingVirtual Group Therapy for IBD Patients With Anxiety and DepressionThis study is being done to better understand the complex relationship between mental health and Inflammatory Bowel Disease (IBD), with a particular focus on symptoms of…NCT07796568·Chicago, Illinois

Active not recruitingA Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not responded at the end of the…NCT03006068·Mobile, Alabama and 491 others

RecruitingA Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative…NCT06095128·Dothan, Alabama and 45 others

CompletedVedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active UC or CD.NCT03138655·Los Angeles, California and 87 others

CompletedA Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyStudy M15-722 is a Phase 2a study to investigate the efficacy and safety of Ravagalimab (ABBV-323) in participants with moderate to severe UC who failed prior therapy.NCT03695185·Tucson, Arizona and 33 others

Enrolling by invitationUtility of Random Biopsies in Patients With Inflammatory Bowel DiseaseThe proposed study is a multicenter parallel group clinical trial that will include 821 evaluable patients per group who will be randomly assigned to either high definition white…NCT06560021·Birmingham, Alabama and 20 others

CompletedA Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisThe objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo in inducing clinical remission (per Adapted Mayo score) in participants with…NCT03653026·Mobile, Alabama and 378 others

CompletedA Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisThe objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active…NCT03398148·Coronado, California and 429 others

CompletedA Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsThis Phase III, double-blind, placebo and active-comparator controlled, multicenter study will investigate the efficacy and safety of etrolizumab in induction of remission in…NCT02163759·Lakewood, Colorado and 87 others

CompletedA Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and FunctionThis exploratory, open-label clinical study aims to explore the effects of KB295, a novel glycan, on adult patients with ulcerative colitis (UC) presenting with mild-to-moderate…NCT04508413·Chicago, Illinois and 2 others

CompletedA Study of Abatacept in Patients With Active Ulcerative ColitisThe purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active ulcerative colitis in patients who have not had an adequate response…NCT00410410·Birmingham, Alabama and 142 others

RecruitingSelenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesMicronutrient deficiencies are common in ulcerative colitis (UC). Selenium deficiency is associated with worse disease outcomes including disease flares and need for surgery.NCT07427017·Chicago, Illinois

TerminatedEfficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisThe purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based on composite score of patient-reported symptoms and centrally read endoscopy, in…NCT03259308·Mesa, Arizona and 206 others

TerminatedTo Evaluate the Impact of SBI on C. Difficile in Hospitalized UC PatientsThe effects of serum-derived bovine immunoglobulin/protein isolate (SBI) will be evaluated and compared to matching placebo in two distinct patient populations: I.NCT02730325·Miami, Florida and 2 others

PreviousPage 2 of 2

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia